SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-11-316380
Filing Date
2011-11-18
Accepted
2011-11-18 08:21:33
Documents
3
Period of Report
2011-11-17
Filing Date Changed
2011-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d257971d8k.htm 8-K 14466
2 PRESS RELEASE d257971dex991.htm EX-99.1 9769
3 GRAPHIC g257971ex99_1pg001.jpg GRAPHIC 28778
  Complete submission text file 0001193125-11-316380.txt   65182
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 111214727
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1